NEW YORK (GenomeWeb News) – Bioinformatics company Cartagenia today announced it received a Canadian medical establishment license for its Cartagenia Bench platform.

The platform is a cloud-based software product for the analysis, interpretation, reporting, and sharing of genomic variants in routine clinical diagnostics. It is CE marked, registered with the US Food and Drug Administration as an exempt Class I Medical Device, and registered in Europe also as a Class I Medical Device, Cartagenia said.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: new gene linked to ocular coloboma, new statistical model for interrogating gene expression networks, and more.

With a new collection, PLOS highlights negative results it has published.

A pair of researchers examines political leanings and views on genomics, finding more of a role for optimism and pessimism in people's views.

The genome of the carnivorous bladderwort is smaller than many other plant genomes, but it still holds on to important genes.